Rehmann Capital Advisory Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $624K | Buy |
2,170
+348
| +19% | +$100K | 0.04% | 308 |
|
|
2025
Q1 | $562K | Buy |
+1,822
| New | +$562K | 0.04% | 332 |
|
|
2019
Q3 | $3.11K | Hold |
39
| – | – | ﹤0.01% | 1324 |
|
|
2019
Q2 | $3.04K | Hold |
39
| – | – | ﹤0.01% | 1680 |
|
|
2019
Q1 | $4.58K | Hold |
39
| – | – | ﹤0.01% | 1553 |
|
|
2018
Q4 | $4.25K | Hold |
39
| – | – | ﹤0.01% | 1297 |
|
|
2018
Q3 | $4.99K | Sell |
39
-80
| -67% | -$10.2K | ﹤0.01% | 1561 |
|
|
2018
Q2 | $13.5K | Hold |
119
| – | – | ﹤0.01% | 1241 |
|
|
2018
Q1 | $13K | Buy |
+119
| New | +$13K | ﹤0.01% | 1224 |
|
|
2014
Q4 | – | Sell |
-1,610
| Closed | -$207K | – | 358 |
|
|
2014
Q3 | $207K | Buy |
+1,610
| New | +$207K | 0.05% | 307 |
|
|
2014
Q1 | – | Sell |
-2,671
| Closed | -$302K | – | 346 |
|
|
2013
Q4 | $302K | Buy |
+2,671
| New | +$302K | 0.09% | 203 |
|